vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $47.3M, roughly 1.8× Mama's Creations, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 1.1%, a 21.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 50.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $3.7M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 33.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
FDMT vs MAMA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $47.3M |
| Net Profit | $19.4M | $540.0K |
| Gross Margin | — | 23.6% |
| Operating Margin | 17.3% | 1.7% |
| Net Margin | 22.8% | 1.1% |
| Revenue YoY | 8508900.0% | 50.0% |
| Net Profit YoY | 139.1% | 31.7% |
| EPS (diluted) | $0.43 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $47.3M | ||
| Q3 25 | $90.0K | $35.2M | ||
| Q2 25 | $15.0K | $35.3M | ||
| Q1 25 | $14.0K | $33.6M | ||
| Q4 24 | $1.0K | $31.5M | ||
| Q3 24 | $3.0K | $28.4M | ||
| Q2 24 | $5.0K | $29.8M | ||
| Q1 24 | $28.0K | $26.7M |
| Q4 25 | $19.4M | $540.0K | ||
| Q3 25 | $-56.9M | $1.3M | ||
| Q2 25 | $-54.7M | $1.2M | ||
| Q1 25 | $-48.0M | $1.6M | ||
| Q4 24 | — | $410.0K | ||
| Q3 24 | $-43.8M | $1.1M | ||
| Q2 24 | $-35.0M | $553.0K | ||
| Q1 24 | $-32.4M | $1.4M |
| Q4 25 | — | 23.6% | ||
| Q3 25 | — | 24.9% | ||
| Q2 25 | — | 26.1% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 24.2% | ||
| Q2 24 | — | 25.0% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | 17.3% | 1.7% | ||
| Q3 25 | -67983.3% | 4.8% | ||
| Q2 25 | -396373.3% | 4.5% | ||
| Q1 25 | -383007.1% | 5.7% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | -1704400.0% | 5.7% | ||
| Q2 24 | -849120.0% | 2.6% | ||
| Q1 24 | -136200.0% | 7.4% |
| Q4 25 | 22.8% | 1.1% | ||
| Q3 25 | -63195.6% | 3.6% | ||
| Q2 25 | -364386.7% | 3.5% | ||
| Q1 25 | -342657.1% | 4.8% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | -1461433.3% | 4.0% | ||
| Q2 24 | -699060.0% | 1.9% | ||
| Q1 24 | -115717.9% | 5.3% |
| Q4 25 | $0.43 | $0.01 | ||
| Q3 25 | $-1.01 | $0.03 | ||
| Q2 25 | $-0.98 | $0.03 | ||
| Q1 25 | $-0.86 | $0.04 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-0.79 | $0.03 | ||
| Q2 24 | $-0.63 | $0.01 | ||
| Q1 24 | $-0.66 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $18.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $49.6M |
| Total Assets | $566.7M | $84.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $18.1M | ||
| Q3 25 | $305.1M | $9.4M | ||
| Q2 25 | $293.2M | $12.0M | ||
| Q1 25 | $321.4M | $7.2M | ||
| Q4 24 | $424.9M | $9.3M | ||
| Q3 24 | $501.9M | $7.4M | ||
| Q2 24 | $541.9M | $13.0M | ||
| Q1 24 | $525.9M | $11.0M |
| Q4 25 | $505.7M | $49.6M | ||
| Q3 25 | $369.0M | $29.6M | ||
| Q2 25 | $420.9M | $26.4M | ||
| Q1 25 | $469.7M | $24.9M | ||
| Q4 24 | $510.6M | $23.0M | ||
| Q3 24 | $552.9M | $22.3M | ||
| Q2 24 | $588.3M | $20.3M | ||
| Q1 24 | $600.6M | $19.6M |
| Q4 25 | $566.7M | $84.0M | ||
| Q3 25 | $424.0M | $51.2M | ||
| Q2 25 | $473.6M | $52.7M | ||
| Q1 25 | $515.7M | $47.1M | ||
| Q4 24 | $560.4M | $47.9M | ||
| Q3 24 | $604.0M | $43.0M | ||
| Q2 24 | $620.1M | $47.2M | ||
| Q1 24 | $629.9M | $45.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $3.9M |
| Free Cash FlowOCF − Capex | $28.5M | $3.7M |
| FCF MarginFCF / Revenue | 33.5% | 7.8% |
| Capex IntensityCapex / Revenue | 0.1% | 0.4% |
| Cash ConversionOCF / Net Profit | 1.47× | 7.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $6.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $3.9M | ||
| Q3 25 | $-46.5M | $-1.7M | ||
| Q2 25 | $-43.4M | $6.0M | ||
| Q1 25 | $-47.8M | $-857.0K | ||
| Q4 24 | $-134.6M | $4.8M | ||
| Q3 24 | $-29.4M | $-2.4M | ||
| Q2 24 | $-30.2M | $3.6M | ||
| Q1 24 | $-29.1M | $6.7M |
| Q4 25 | $28.5M | $3.7M | ||
| Q3 25 | $-46.6M | $-2.2M | ||
| Q2 25 | $-43.4M | $5.5M | ||
| Q1 25 | $-48.4M | $-930.0K | ||
| Q4 24 | $-138.4M | $2.5M | ||
| Q3 24 | $-31.2M | $-4.0M | ||
| Q2 24 | $-30.6M | $2.5M | ||
| Q1 24 | $-29.8M | $6.6M |
| Q4 25 | 33.5% | 7.8% | ||
| Q3 25 | -51765.6% | -6.2% | ||
| Q2 25 | -289620.0% | 15.5% | ||
| Q1 25 | -345635.7% | -2.8% | ||
| Q4 24 | -13837100.0% | 8.0% | ||
| Q3 24 | -1038966.7% | -14.1% | ||
| Q2 24 | -611840.0% | 8.4% | ||
| Q1 24 | -106421.4% | 24.8% |
| Q4 25 | 0.1% | 0.4% | ||
| Q3 25 | 101.1% | 1.5% | ||
| Q2 25 | 440.0% | 1.5% | ||
| Q1 25 | 4507.1% | 0.2% | ||
| Q4 24 | 378600.0% | 7.2% | ||
| Q3 24 | 59266.7% | 5.6% | ||
| Q2 24 | 6980.0% | 3.8% | ||
| Q1 24 | 2535.7% | 0.4% |
| Q4 25 | 1.47× | 7.16× | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | 4.85× | ||
| Q1 25 | — | -0.54× | ||
| Q4 24 | — | 11.71× | ||
| Q3 24 | — | -2.10× | ||
| Q2 24 | — | 6.58× | ||
| Q1 24 | — | 4.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
